Literature DB >> 172520

Pyridine nucleotide metabolism in mitotic cells.

G Elliott, M Rechsteiner.   

Abstract

The biosynthesis and turnover of nicotinamide adenine dinucleotide (NAD) have been examined in mitotic cells of the human culture line, D98/AH2. No significant difference in the incorporation of nicotinic acid or nicotinamide could be detected between mitotic and interphase cells. The distribution of newly-incorporated nicotinic acid among the various pyridine nucleotides was also identical in mitotic and interphase cells. Whereas previous results have shown that the nucleus is necessary for NAD biosynthesis, the present results show that an intact nucleus is not required. In contrast to the equivalent rates of biosynthesis in mitotic and interphase cells, the pyridine ring of NAD was lost twice as fast from mitotic as from interphase cells. Loss of the pyridine ring to the medium is not necessarily an accurate measure of turnover, and the difference between mitotic and interphase cells may reflect differential reutilization of the pyridine ring within the cell. However, it is clear that NAD turnover is substantial in mitotic cells and possibly greater in mitotic cells than interphase cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172520     DOI: 10.1002/jcp.1040860509

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Microinjection of ubiquitin: intracellular distribution and metabolism in HeLa cells maintained under normal physiological conditions.

Authors:  N Carlson; M Rechsteiner
Journal:  J Cell Biol       Date:  1987-03       Impact factor: 10.539

Review 2.  Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?

Authors:  Paul O Hassa; Sandra S Haenni; Michael Elser; Michael O Hottiger
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

Review 3.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

4.  Loss of canine myocardial nicotinamide adenine dinucleotides determines the transition from reversible to irreversible ischemic damage of myocardial cells.

Authors:  H H Klein; J Schaper; S Puschmann; C Nienaber; H Kreuzer; W Schaper
Journal:  Basic Res Cardiol       Date:  1981 Nov-Dec       Impact factor: 17.165

Review 5.  Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders.

Authors:  Sarika Srivastava
Journal:  Clin Transl Med       Date:  2016-07-27

Review 6.  Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule.

Authors:  Yasir S Elhassan; Andrew A Philp; Gareth G Lavery
Journal:  J Endocr Soc       Date:  2017-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.